Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
31.08
-1.01 (-3.15%)
At close: Apr 28, 2026, 4:00 PM EDT
30.92
-0.16 (-0.51%)
Pre-market: Apr 29, 2026, 4:43 AM EDT
Smith & Nephew Revenue
In the year 2025, Smith & Nephew had annual revenue of $6.16B with 6.09% growth. Smith & Nephew had revenue of $3.20B in the half year ending December 31, 2025, with 13.78% growth.
Revenue (ttm)
$6.16B
Revenue Growth
+6.09%
P/S Ratio
2.17
Revenue / Employee
$362,844
Employees
16,988
Market Cap
13.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.16B | 354.00M | 6.09% |
| Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
| Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
| Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
| Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Koninklijke Philips | 20.94B |
| Zimmer Biomet Holdings | 8.23B |
| STERIS | 5.83B |
| DexCom | 4.66B |
| Globus Medical | 2.94B |
| Insulet | 2.71B |
| Bio-Rad Laboratories | 2.58B |
| Bio-Rad Laboratories | 2.58B |
SNN News
- 10 hours ago - Is Smith & Nephew PLC (SNN) a Bargain After 3.1% Drop? GF Value Says Undervalued - GuruFocus
- 7 days ago - A Look at Smith & Nephew PLC (SNN) After 4.0% Decline -- GF Value $31.12 vs Price $32.84 - GuruFocus
- 7 days ago - Smith+Nephew (SNN) Reports Positive Trial Results for Cartilage Repair Implant - GuruFocus
- 14 days ago - Smith & Nephew Breaks Above 200-Day Moving Average - Bullish for SNN - Nasdaq
- 19 days ago - Smith & Nephew (SNN) Reports Positive Trial Results for Rotator Cuff Implant - GuruFocus
- 19 days ago - Smith+Nephew's REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,* - Benzinga
- 5 weeks ago - Cevian Capital II GP LTD Acquires Significant Stake in Smith & Nephew PLC - GuruFocus
- 5 weeks ago - BlackLine, Smith & Nephew, and More Stocks See Action From Activist Investors - Barron's